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ER stress in rodent islets of Langerhans is concomitant with
obesity and b-cell compensation but not with b-cell dysfunction
and diabetes
O Omikorede1, C Qi1, T Gorman2, P Chapman3, A Yu3, DM Smith4 and TP Herbert1
OBJECTIVE: The objective of this study was to determine whether ER stress correlates with b-cell dysfunction in obesity-associated
diabetes.
METHODS: Quantitative RT-PCR and western blot analysis were used to investigate changes in the expression of markers of ER
stress, the unfolded protein response (UPR) and b-cell function in islets isolated from (1) non-diabetic Zucker obese (ZO) and obese
female Zucker diabetic fatty (fZDF) rats compared with their lean littermates and from (2) high-fat-diet-fed fZDF rats (HF-fZDF), to
induce diabetes, compared with age-matched non-diabetic obese fZDF rats.
RESULTS: Markers of an adaptive ER stress/UPR and b-cell function are elevated in islets isolated from ZO and fZDF rats compared
with their lean littermates. In islets isolated from HF-fZDF rats, there was no signiﬁcant change in the expression of markers of ER
stress compared with age matched, obese, non-diabetic fZDF rats.
CONCLUSIONS: These results provide evidence that obesity-induced activation of the UPR is an adaptive response for increasing
the ER folding capacity to meet the increased demand for insulin. As ER stress is not exacerbated in high-fat-diet-induced diabetes,
we suggest that failure of the islet to mount an effective adaptive UPR in response to an additional increase in insulin demand,
rather than chronic ER stress, may ultimately lead to b-cell failure and hence diabetes.
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INTRODUCTION
Type-2 diabetes mellitus (T2DM) is a disorder that is characterised
by high blood glucose concentration in the context of insulin
resistance and/or relative insulin deﬁciency. It causes metabolic
changes that lead to the damage and functional impairment of
organs and tissues, resulting in increased morbidity and mortality.
It is the prevalence of this form of diabetes that is increasing at an
alarming rate because of the ‘obesity epidemic’, as obesity is a key
risk factor in the development of insulin resistance. Although
insulin resistance contributes to the pathogenesis of T2DM, it is
the failure of pancreatic b-cells to secrete sufﬁcient insulin to
maintain normoglycemia, due to a decrease in b-cell function and
mass, that results in the development of T2DM (for reviews
see:1–3). Yet, the underlying molecular mechanisms that cause the
loss of b-cell mass in T2DM are poorly understood. Interestingly,
the chronic incubation of isolated islets of Langerhans or clonal
b-cell lines with FFAs leads to cell dysfunction and death, which is
associated with the induction of ER stress and chronic activation of
the unfolded protein response (UPR).4–8 Moreover, markers of ER
stress have been found in islets from obese diabetic db/db mice6
and in b-cells from non-BMI-matched pancreatic sections from
type-2 diabetics compared with non-diabetics.6 On the basis of
these observations, it has been hypothesised that, in obese
individuals, elevated circulatory FFAs act on the b-cell to cause ER
stress, resulting in b-cell dysfunction and death.9 However, there is
little in vivo correlative evidence to support this and, indeed, little
to no change in the expression of markers of ER stress was
observed in BMI-matched non-diabetic obese versus type-2
diabetic obese subjects, although an increase in ER mass was
detected in the islets of type-2 diabetic obese subjects.10
Zucker Obese (ZO) rats lack a functional leptin receptor, which
results in hyperphagia, obesity and insulin resistance.11 Yet, these
animals remain normoglycemic through a compensatory increase
in insulin secretion maintained through increased b-cell mass and
possibly function.12–14 Selective inbreeding of glucose-intolerant
ZO rats led to the establishment of Zucker diabetic fatty (ZDF)
rats.11 Male ZDF (mZDF) rats spontaneously develop diabetes
between 6 and 12 weeks of age. This is concomitant with a failure
of b-cells to adequately adapt to an increase in demand, followed
by a decline in b-cell function and mass.12,13,15,16 These rats have
high levels of circulating FFAs and their islets are susceptible to
lipotoxicity.17 Therefore, it has been suggested that b-cell
dysfunction and death in vivo are due to b-cell lipotoxicity.17 In
contrast, female ZDF (fZDF) rats, although obese and glucose
intolerant, are not diabetic because of b-cell compensation.11,15
These animals do not develop diabetes unless they are placed on
a high-fat diet (HFD), which results in decreased insulin sensitivity
and a failure of the b-cell to adequately compensate, followed by
a progressive decrease in b-cell function and mass.11,15,18–21
HFD-fed fZDFs (HF-fZDFs) have been proposed to be a good
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animal model of diet-induced T2DM.18 Therefore, using ZO and
fZDF rats as models of obesity and HF-fZDF rats as a model of diet-
induced diabetes, we investigated whether there is a correlation
between ER stress in the islets of Langerhans and (1) obesity and
(2) HFD-induced diabetes.
METHODS AND PROCEDURES
Chemicals
FCS (foetal calf serum) was purchased from Invitrogen (Life Technologies,
Carlsbad, CA, USA). All other chemicals were obtained from Sigma-Aldrich
(St Louis, MO, USA) (unless otherwise stated).
Animal care and dietary treatment
Animals were kept under standard laboratory conditions with free access
to food and water. All animals used in these studies were purchased from
Charles River Laboratories (Wilmington, MA, USA). Where indicated
12-week-old fZDF were fed either a HFD (60% fat, 20% protein, 20%
carbohydrate; D12492; Research Diets, New Brunswick, NJ, USA) or control
chow diet (CD, 7.5% fat, 17.5% protein, 75% carbohydrate; RM1, Special
Diets Services, Witham, Essex, UK) for 7 weeks.
Metabolite assays
Tail blood from 16-h-fasted rats was assessed for plasma insulin using an
enzyme-linked immunosorbent assay (Ultrasensitive Rat Insulin ELISA kit;
Mercodia, Uppsala, Sweden) and glycated haemoglobin (HbA1c) using a
Variant II analyser (Bio-Rad, Hercules, CA, USA).
Islet isolation
Rats were euthanised by CO2/O2 narcosis and cervical dislocation (without
recovery from narcosis). The rats were then weighed and the pancreas was
rapidly removed. The islets of Langerhans were isolated as previously
described.22
RNA isolation
RNA was extracted as per the manufacturer’s instruction (Qiagen RNeasy
microkit, Qiagen, Venlo, the Netherlands). The RNA was then DNAse1
(Qiagen)-treated and stored at  80 1C until required. RNA concentration
was determined using a Nanodrop ND-1000 spectrophotometer (Thermo-
scientiﬁc, Waltham, MA, USA).
Gene expression analysis using TaqMan low-density arrays (TLDA)
Predesigned TaqMan primers and probe sets (Table 1) were factory-loaded
into the 384 wells of TaqMan low-density arrays (TLDAs; Applied
Biosystems, Life Technologies, Carlsbad, CA, USA) as 48 genes per sample
with eight samples per card. RNA of 4 mg was complexed to oligo(dT)
(0.5 ug ul 1) and cDNA was generated using Superscript Reverse
Transcriptase III (Invitrogen) as per the manufacturer’s instructions. cDNA,
equivalent to 110 ng of starting RNA, was mixed with TaqMan Universal
PCR Master Mix (Applied Biosystems, Life Technologies) and transferred
into a TLDA. Thermal cycling was performed on an Applied Biosystems
Prism 7900HT sequence detection system as follows: 2min at 50 1C, 10min
at 95 1C, 15 s at 95 1C and 1min at 60 1C for 40 cycles. Expression values
were calculated using the comparative CT method as previously
described.23 Expression levels of target genes were normalised to 18S
ribosomal RNA. Results were expressed as means±s.e.m.
Individual TaqMan quantitative RT-PCR
Pre-selected mRNAs were assessed by quantitative RT-PCR using the
TaqMan RNA-to-CT 1-step kit (Applied Biosystems). Pre-complexed primers
were purchased from Applied Biosystems (ABI; Foster City). All samples
were run in triplicate on an Applied Biosystems 7900/7700 machine.
Expression levels were calculated using the comparative CT method as
previously described.23 Results were normalised to 18S ribosomal RNA and
expressed as fold change.
MIN6 cell culture and treatment
In this study, Mouse insulinoma-6 (MIN6) cells24 were cultured, treated and
prepared for SDS-PAGE as previously described.25
SDS-polyacrylamide gel electrophoresis (PAGE) and western blotting
The islets were immediately lysed in 1x Laemmli sample buffer (0.1%
2-Mercaptoethanol, bromophenol blue, 10% Glycerol, 2% SDS, 63mM Tris-HCl
(pH 6.8)), boiled and then stored at  80 1C before western blot analysis.
SDS-PAGE and western blotting were performed as described previously.26
Anti- phospho-JNK, JNK and rpS6 antibodies were purchased from Cell
Signaling Technology (Beverly, MA, USA). Anti-CHOP, ATF4, calreticulin and
HYOU1 antibodies were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-phospho-eIF2a (Ser51), anti-GRP78, anti-phospho-IRE1
and anti-GRP98 antibodies were purchased from Biosource (Camarillo, CA,
USA), BD-signal transduction (Sparks, MD, USA), Novus Biologicals
(Cambridge, UK) and Abcam (Cambridge, UK), respectively. Detection was
by horseradish peroxidase-linked secondary antibodies and enhanced
chemiluminescence (Cheshire Sciences Ltd, Cheshire, UK).
Statistical analysis
Comparisons of more than two groups were made using two-way analysis
of variance. A difference was deﬁned as signiﬁcant when Po0.05.
RESULTS
ER stress in the islets of Langerhans isolated from Zucker obese rats
To determine whether obesity is associated with ER stress and the
induction of the UPR in b-cells, islets of Langerhans were isolated
from 11-week-old male Zucker Obese (ZO) rats (fa/fa) and their
age-matched lean littermates (Fa/fa), and differences in the
expression of 41 selected mRNAs (see Table 1), including 27
markers of ER stress, markers of b-cell function, differentiation and
lipid handling, were determined using Taqman Low-Density
Arrays (TLDAs). The 11-week-old ZO rats used in this study
weighed signiﬁcantly more than their lean littermates fed on the
same standard chow diet (Figure 1ai). In addition, they were
hyperinsulinemic but maintained fairly normal glycemic control
(Figures 1aii and aiii). The expression of 21 out of 27 markers of ER
stress (that is, 78%) increased by 1.5X or more in the islets of
ZO rats compared with their lean littermates. These included
mRNAs encoding chaperone proteins, quality control proteins
and foldases, such as hypoxia-upregulated 1 (Hyou1), protein
disulphide isomerase family A member 4 (Pdia4), calreticulin (Calr),
heat shock 70 kDa protein 5 a.k.a BiP (Hspa5), protein disulphide
isomerase family A member 3 (Pdia3) and calnexin (Canx). Other
characteristic markers of ER stress were also upregulated,
including activating transcription factor 4 (Atf4), DNA damage-
inducible transcript-3/C/EBP homologous protein (Ddit3/Chop),
and growth arrest and DNA damage-inducible gene 34 (Gadd34/
Myd116). Signiﬁcant increases in the expression of markers of
b-cell function, such as insulin-2 (Ins2), were also detected in the
islets of ZO rats, indicative of b-cell compensation. There was also
evidence of increased lipid handling and metabolism in the islets
of ZO rats as the expression levels of HMG-CoA reductase (Hmgcr),
sterol regulatory element binding protein-1 (Srebf1), low-density
lipoprotein receptor (Ldlr) and fatty acid synthase (Fasn) were all
signiﬁcantly increased (Figure 1b).
To conﬁrm the differences in the expression of markers of ER
stress in the islets of ZO versus lean rats obtained using TLDA, a
more stringent assessment of changes in the mRNA expression
was made using single-gene RT-qPCR. In agreement with the
TLDA data, the expression levels of the ER stress markers
calreticulin, Hspa5 (BiP), Hyou1/Orp150, Pdia4, growth arrest and
DNA damage-inducible 45a (Gadd45A), Ddit3/Chop, caspase-12
(Casp12) and nucleobindin (Nucb1) were all signiﬁcantly upregu-
lated in the islets of ZO rats compared with lean control rats
(Figure 1c). Moreover, the expression of an additional ER stress
marker, ER-oxidoreductin 1b (Ero1b), was upregulated in the islets
of ZO rats compared with lean control rats (Figure 1c). However, in
contrast to the TLDA data, no signiﬁcant increase in the mRNA
expression of Atf4 was detected (Figure 1c). Nonetheless, taken
together, the data provide evidence that the islets from ZO rat
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have undergone an adaptive UPR, which is indicative of previous,
and possibly continued, exposure to increased levels of ER stress.
ER stress in the islets of Langerhans isolated from female Zucker
diabetic female (fZDF) rats
To investigate whether obesity also correlates with the induction
of UPR in islets from an alternative rodent model of obesity,
expression of key markers of ER stress were assessed in obese
female Zucker diabetic fatty (fZDF) rats (fa/fa) and their
heterozygous lean littermates (Fa/fa). Unlike male ZDF rats, fZDF
rats do not spontaneously develop diabetes and maintain
normoglycemia despite insulin resistance through compensatory
increases in insulin secretion.18 The 12-week-old fZDF rats used in
this study weighed signiﬁcantly more than their age-matched lean
littermates, maintained good glycemic control and were
characteristically hyperinsulinemic (Figure 2a).
Using TLDAs (list of genes shown in Table 1), it was found that
the mRNA expression of nearly all markers of ER stress analysed
increased in the islets of fZDF rats in comparison with their lean
littermates. Of these, the expression of 52% increased by more
than 1.5-fold or more. These included Pdia4, Calr, Hspa5 (BiP),
Pdia3 and Ddit3 (CHOP) mRNA (Figure 2b). In addition, there were
signiﬁcant increases in the mRNA expression of insulin 2 (Ins2),
insulin receptor substrate (Irs2) and glucose transporter-2 (Glut2/
Slc2a2), markers of b-cell function and differentiation, and Srebf1,
Ldlr and Hmgcr, markers of lipid handling and metabolism
(Figure 2b).
To conﬁrm the results obtained using TLDA, the expression of a
selected set of genes encoding markers of ER stress was analysed
Table 1. List of genes on the Taqman low-density array (TLDA) whose mRNA expression was determined by qPCR
Markers of ER stress Gene Aliases Ref seq Rat assay no
Activating transcription factor 3 Atf3 NM012912.1 Rn00563784_m1
Activating transcription factor 4 Atf4 CREBP2 NM024403.1 Rn00824644_g1
Activating transcription factor 5 Atf5 Atfx NM172336.3 Rn00597319_m1
CCAAT/Enhancer binding protein, beta C/EBPb LAP/TF5/NF-IL6 NM024125.4 Rn00824635_s1
Calreticulin Calr NM022399.2 Rn00574451_m1
Calnexin Canx NM172008.2 Rn00596877_m1
Caspase 12 Casp 12 Rn00590440_m1
Growth arrest and DNA damage-inducible protein Ddit3 GADD153/CHOP(10) NM024134 Rn00492098_g1
DnaJ (Hsp40) homologue, subfamily B, member 9 Dnajb9 ERdj4 NM012699.2 Rn00562259_m1
DnaJ (Hsp40) homologue, subfamily C, member 3 Dnajc3 HSP40, DnaJ, p58 NM022232.1 Rn00573712_m1
PRKR-like endoplasmic reticulum kinase Eif2ak3 PERK/PEK NM031599.1 Rn00581002_m1
FK506 binding protein 11 FkBP11 FkBP19 NM001013105.1 Rn01532810_m1
Growth arrest and DNA damage-inducible, alpha Gadd45a DDIT1 NM024127.2 Rn00577049_m1
Homocysteine-inducible, ER stress-inducible Herpud1 Herp, Mif1 NM053523.1 Rn00585371_m1
Heat shock 70 kDa protein 5 Hspa5 BiP/GRP78 NM013083.1 Rn00565250_m1
Hypoxia upregulated 1 Hyou1 orp150/Cab140 NM138867.2 Rn00593982_m1
Mitogen-activated protein kinase 8 Mapk8 JNK XM341399.3 Rn01453358_m1
Myeloid differentiation primary response gene 116 Myd116 GADD34 NM133546.2 Rn00591894_m1
Nucleobindin Nucb1 NM053463.1 Rn00584973_m1
Protein disulphide isomerase family A, member 3 Pdia3 ERp57/GRP58 NM017319 Rn00569027_m1
Protein disulphide isomerase family A, member 4 Pdia4 ERp72/ERP70 NM053849.1 Rn00587766_m1
Paraoxonase 2 Pon2 NM001013082.1 Rn01456019_m1
Quiescin Q6 sulfhydryl oxidase 1 Qscn6 qsox1 NM053431.3 Rn00584808_m1
Tribbles 3 Trib3 SINK/SKIP3 NM144755.2 Rn00595314_m1
UDP-glucose ceramide glucosyltransferase-like 1 Ugcgl1 UGGT/UGTR NM133596.1 Rn00592293_m1
Wolframin Wfs1 DFNA14 NM031823.1 Rn00582735_m1
X-box binding protein 1 Xbp1 TREB5 NM001004210.1 Rn01752572_g1
Markers of b-cell function and differentiation Gene Aliases Ref seq Rat assay no
Cyclin D1 Ccnd1 PRAD1 NM007631 Rn00432359_m1
Glucokinase/ Hexokinase 4 Gck MODY2/HK4 NM010292 Rn00561265_m1
Insulin 2 Ins2 NM008387 Rn01774648_g1
Insulin receptor substrate 2 Irs2 NM001168633.1 Rn01482270_s1
Pancreatic and duodenal homeobox 1 Pdx1 MODY4 NM008814 Rn00755591_m1
Glucose transporter type 2 Slc2a2 GLUT2 X78722 Rn00563565_m1
Markers of lipid handling and metabolism Gene Aliases Ref seq Rat assay no
Acetyl CoA carboxylase Acaca ACCA AAG01858 Rn00573474_m1
Fatty acid synthase Fasn Fas NM007988 Rn00569117_m1
Free fatty acid receptor 1 Ffar1 GPR40 NM153304.1 Rn00824686_s1
HMG-CoA reductase Hmgcr M62766 Rn00565598_m1
Low density lipoprotein receptor Ldlr FHC NM010700 Rn00598438_m1
Sterol regulatory element binding protein–1 Srebp1 ADD1 XM213329.4 Rn01495763_g1
Miscellaneous Gene Aliases Ref seq Rat assay no
Uncoupling protein 2 Ucp2 SLC25A8 U69135 Rn01754856_m1
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Figure 1. Obesity leads to increased ER stress in ZO rats. (ai) Body weight in grams, (aii) plasma insulin after an overnight fast and (aiii) % GHb
in age-matched Zucker rats (obese) and their lean littermates (lean). (b) Differential gene expression between Zucker rats (obese) and their
lean littermates (lean) assessed using TLDA is expressed as a fold change and normalised to 18S ribosomal RNA. Data are shown as
mean±s.e.m. (Zucker obese, n¼ 5; lean control, n¼ 4). (c) Relative expression of selected transcripts from the islets of Zucker rats (obese) and
their lean littermates (lean) assessed by single-gene Taqman RT-qPCR. Results are expressed as relative expression levels and normalised to
the housekeeping gene ribosomal protein P2 (RPP2). Values are mean±s.e.m. determined from control lean (n¼ 4) and obese rats (n¼ 5).
Statistical significance was determined using an unpaired two-tailed Student t-test. *Po0.05; **Po0.01; ***Po0.001 obese versus lean control
for each gene.
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Figure 2. Obesity leads to increased ER stress in female ZDF rats. (ai) Body weight in grams, (aii) plasma insulin after an overnight fast and
(aiii) %GHb in fZDF rats (obese) and their lean littermates (lean). (b) Differential gene expression in the islets of fZDF rats (obese) and their lean
littermates (lean) assessed using TLDA is expressed as a fold change and is normalised to 18S ribosomal RNA. Data are shown as mean±s.e.m.
(n¼ 3). (c) Relative expression of selected transcripts from the islets of fZDF rats (obese) and their lean littermates (lean) by single-gene
Taqman RT-qPCR. Results are expressed as relative expression levels and normalised to ribosomal protein P2 (RPP2). Values are mean±s.e.m.
determined from control lean (n¼ 3) and obese rats (n¼ 3). Statistical significance was determined using an unpaired two-tailed Student
t-test. *Po0.05; **Po0.01; ***Po0.001 obese versus lean control for each gene.
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by single-gene RT-qPCR (Figure 2c). The expression levels of
mRNAs encoding Calr, Hspa5, Pdia4 and Nucb1 were all found to
be signiﬁcantly upregulated in the islets of fZDF rats in
comparison with lean controls, indicative of an adaptive UPR
(Figure 2c). Although there was a trend towards an increase in the
expression of mRNA encoding other markers of ER stress (that is,
caspase-12, Hyou1, Gadd45A, Ddit3/Chop and C/ebpb), these
differences proved statistically insigniﬁcant (Figure 2c). In addition,
there were no differences in the expression of Ero1b, Atf3 and Atf4
(Figure 2c). Nonetheless, taken together, these results provide
evidence that a subset of mRNA, reported to be upregulated in
response to ER stress, is upregulated in the islets of fZDF rats
compared with their lean littermates.
ER stress in the islets of Langerhans isolated from age-matched
fZDF rats compared with high-fat-fed fZDF (HF-fZDF) rats
To investigate whether there is a correlation between the
development of obesity-associated diabetes and ER stress
signalling, fZDF rats were placed on a high-fat diet (HFD) for 7
weeks to induce diabetes. This has been shown to correlate with a
decrease in b-cell function.18 HFD-fed fZDF rats (HF-fZDF) weighed
signiﬁcantly more than their obese littermates fed on a standard
chow diet for the same duration (Figure 3ai). These rats also had
reduced fasting plasma insulin concentrations (Figure 3aii),
suggestive of b-cell dysfunction, and increased glycohemoglobin
(GHb) (Figure 3aiii), indicative of chronic hyperglycemia.
RNA was extracted from the islets of Langerhans isolated from
these rats and the comparative expression levels of markers of ER
stress between fZDF and the HF-fZDF rats were assessed using
TLDAs (see Table 1). The expression of all the markers of ER stress
either decreased or was unchanged in the islets isolated from
HF-fZDF compared with the chow-fed fZDF (Figure 3b). Markers of
b-cell function and differentiation, including the expression of
insulin-2 (Ins2), Glut2 (Slc2a2), glucokinase (Gck) and Pdx1, were
signiﬁcantly decreased in the islets of the HF-fZDF rats in
comparison with chow-fed control fZDF rat islets (Figure 3b),
suggestive of a decrease in b-cell function and indicative of b-cell
de-differentiation. Surprisingly, there were also signiﬁcant
decreases in the expression of mRNAs involved in lipid handling
and metabolism, including Srebf1 and Ldlr (Figure 3b). The
expression of Ucp2, which has been reported to be upregulated
upon exposure to FFAs,27 was also signiﬁcantly reduced in the
islets of the HF-fZDF rats compared with chow-fed fZDF control
rats (Figure 3b).
To conﬁrm the results obtained using TLDA, the expression of a
selected set of mRNAs encoding markers of ER stress was analysed
by single-gene RT-qPCR (Figure 3c). No signiﬁcant changes in the
expression of these selected markers of ER stress were detected,
including Hyou1, Hspa5 (BIP) or Ddit3 (CHOP). Changes in the
expression of insulin mRNA were also investigated. Although there
was a trend towards a decrease in the expression of insulin,
possibly mediated though a decrease in b-cell number per islet,
these changes proved insigniﬁcant. Moreover, normalisation of
the expression of markers of ER stress using insulin as the
reference gene also revealed no signiﬁcant increase in the
expression of markers of ER stress in HFD-fed animals (results
not shown). This is of importance as it provides evidence that
potential changes in b-cell number per islet through increased
rates of apoptosis and/or dedifferentiation are unlikely to have
had any signiﬁcant effect on the results presented. Taken
together, these results indicate that, in this model of diabetes,
there are no increases in the mRNA expression of markers of ER
stress in the islets of diabetic versus non-diabetic animals.
However, changes in mRNA expression do not necessarily reﬂect
changes in protein expression. Therefore, changes in protein
expression of selected markers of ER stress in the islets isolated
from three age-matched, lean (Fa/fa), fZDF (obese) and HD-fZDF
(obese diabetic) rats were determined by Western blot analysis.
The expression levels of calreticulin, HSPA5/BIP, HYOU1 and CHOP
were all increased in the islets of fZDF rats compared with their
lean control (Figure 4a), thus generally reﬂecting differences in
mRNA expression determined by TLDA and single-gene RT-qPCR
analysis (Figures 2b and c). Yet, no difference in the expression of
these markers of ER stress was detected in the islets of HF-fZDF
rats compared with fZDF rats (Figure 4a), thus conﬁrming the
mRNA expression data (Figures 3b and c). These data provide
evidence that, in this model of diabetes, there are no increases in
the expression of markers of ER stress in the islets from age-
matched obese diabetic versus obese non-diabetic animals. CHOP
expression can be upregulated through an increase in PERK-
dependent phosphorylation of eukaryotic initiation factor 2a
(eIF2a). However, no signiﬁcant changes in eIF2a phosphorylation
were detected between the groups (Figure 4a).
The phosphorylation status of c-jun N-terminal kinase (JNK), a
marker of cellular stress, was also examined by western blot
analysis. A signiﬁcant increase in the phosphorylation state of JNK
was observed in the islets of fZDF rats in comparison with lean
controls (Figure 4b). However, no statistically signiﬁcant increase in
the phosphorylation of JNK was observed in the islets of HF-fZDF
rats in comparison with fZDF (Figure 4b). JNK phosphorylation can
be activated by the chronic activation of IRE1.28 However, no
phosphorylation of IRE1 (an indicator of its activity) was detected in
the ZDF islets, although IRE1 phosphorylation was detected in both
control and thapsigargin-treated Wistar rat islets (Figure 4a).
DISCUSSION
Zucker Obese (ZO) and obese fZDF rats maintain glucose
homeostasis despite severe insulin resistance through an adaptive
compensation in b-cell mass and function.12–15,19,20,29–31 This is
supported by the results presented in this report showing that the
expression levels of mRNAs implicated in b-cell function, growth
and differentiation, such as Pdx1, Ccnd1 (cyclin-D1), Slc2a2 (Glut2)
and Gck (glucokinase), are increased in the islets of these rodent
models of obesity (Figures 1 and 2), and, although we have not
examined b-cell function or growth directly in this study, many
other investigators have. For example, Goh et al. demonstrated,
using the two-step hyperglycaemic clamp method, that basal
insulin secretion is elevated but glucose-stimulated insulin
secretion (GSIS) in vivo is normal in both obese Zucker and
female ZDF rats (fZDF).32 Moreover, a number of groups
have reported adaptations in key metabolic pathways in Zucker
rats.29–31 In addition, increased b-cell mass in these animal models
has been shown to be mediated, at least in part, by an increase
in b-cell number and size.13,14,19,20
Importantly, in this study we show that there is an increase in
the expression of markers of ER stress, including the ER
chaperones and foldases Hyou1, Hspa5 (BiP), Pdia4, Calr (calreti-
culin) and Calx (calnexin) (Figures 1, 2, 4 and 5). These proteins are
important in increasing protein folding capacity in the ER, and
thus the upregulation of their expression is likely an important
compensatory adaptation to facilitate the increase in insulin
synthesis required to maintain enhanced b-cell function. In
accordance with this, the obese rats in this study were signiﬁcantly
hyperinsulinemic. Although obesity led to an increase in many
markers of ER stress, there was little evidence to indicate sustained
activation of the UPR in these islets. For example, we could not
detect any increase in the phosphorylation of IRE1 and eIF2a
(Figure 4), nor could we detect any signiﬁcant increase in the
expression of Atf4 and Xbp1 (Figures 1 and 2), proximal targets of
PERK and IRE1, respectively9 (Figure 5). Yet, the phosphorylation of
JNK (Figure 4), a kinase that can be activated by chronic IRE1
activation,28 is elevated in the islets of these obese animals, as is
the expression of CHOP (Figure 4), a potentially pro-apoptotic
protein that can be upregulated through both the IRE1 and PERK
ER stress, obesity and diabetes
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Figure 3. Obesity-induced ER stress in the islets of Langerhans is not exacerbated by diet-induced diabetes. (ai) Body weight in grams, (aii)
plasma insulin after an overnight fast and (aiii) %GHb in chow-fed fZDF rats and HF-fZDF rats. (b) Differential gene expression in the islets of
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by single-gene Taqman RT-qPCR. Results are expressed as relative expression levels and normalised to ribosomal protein P2 (RPP2). Values are
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arms of the UPR33,34 (Figure 5). Increased CHOP expression and JNK
phosphorylation is often provided as evidence for chronic ER stress.
However, both of these proteins can be upregulated/activated in
response to a diverse range of stresses including oxidative and
inﬂammatory stress,35–38 which have been reported to occur in and
contribute to b-cell dysfunction and death in the development of
T2DM (for review, see Poitout and Robertson39). Regardless of
whether these changes in CHOP expression and JNK
phosphorylation are, or are not, a result of ER stress, the islets are
clearly stressed but this stress is not, in and of itself, sufﬁcient to lead
to the development of b-cell dysfunction and apoptosis in the islets
of these obese rodents. Taken together, we conclude that, with the
development of obesity and an increase in insulin demand, the
b-cells experience ER stress, resulting in an adaptive UPR that is
necessary to effectively sustain the increase in insulin demand
brought about by both insulin resistance and increased body mass.
Although the islets from these obese animals show signs of stress,
the source of this stress is far from clear and, apparently, does not
adversely affect b-cell function. Interestingly, Chan et al. recently
reported that b-cell compensation in obese mice also correlates with
an increase in the expression of markers of an adaptive UPR.40
fZDF rats, fed a high-fat diet (HF-fZDF), develop type-2 diabetes.
This has been shown to be concomitant with failure of the b-cells
to adequately compensate, followed by a decrease in b-cell
function and mass manifested by a progressive decline in
plasma insulin levels accompanied by a rise in plasma glucose
concentration.19–21,32,41 In agreement with these previous studies,
we also show that HF-fZDF animals have decreased plasma
insulin.18–20 In addition, we show that these animals have
decreased insulin expression and a decrease in the expression
of markers of b-cell function and differentiation, suggestive of a
decline in b-cell function (Figure 3b). This is consistent with studies
demonstrating the loss of GSIS and a drop in the disposition index
in HF-fZDF rats.32,41 Previous reports have suggested that
progressive b-cell dysfunction in models of type-2 diabetes is
caused, at least in part, through chronic ER stress, possibly as a
result of elevated levels of circulating FFAs and glucose.42
However, compared with obese, chow-fed and age-matched
fZDF rats, metabolic changes in the HF-fZDF were not
accompanied by an increase in the expression of markers of ER
stress/UPR (Figures 3 and 4). Importantly, these results are in
agreement with microarray data from human subjects, which
showed little to no changes in the expression of markers of ER
stress in b-cell-enriched samples isolated from BMI-matched
obese non-diabetic versus obese type-2 diabetic subjects.10
Moreover, we showed that there was no potentiation in the
expression of the pro-apoptotic proteins CHOP and caspase-12 or
any increase in the phosphorylation of JNK (Figures 3 and 4).
However, it is possible that there is increased nuclear localisation
of CHOP mediated, for example, through an increase in liver
inhibitory protein (LIP) expression, an isoform of C/EBPb.43 These
observations indicate that, at least in this rodent model of HFD-
induced diabetes, increased obesity, insulin resistance and insulin
demand fail to increase ER stress and/or further activate the UPR.
This conclusion is supported by recently published ﬁndings
showing that the progression of b-cell dysfunction in diabetes
prone db/db mice does not correlate with an increase in the
expression of either ATF4 or CHOP.40
Interestingly, the culturing of ‘compensated’ islets in FFA isolated
from pre-diabetic mZDF rats resulted in a decrease in b-cell function
and a reduction in pre-existing compensatory changes that had
occurred in vivo.44 It is therefore possible that the development of
b-cell dysfunction and apoptosis in obesity-associated type-2
diabetes occurs as a result of a failure of the UPR to further adapt
to increased demand as opposed to the chronic activation of UPR
signalling. In support of this, BiP overexpression in b-cells protects
mice from high-fat-diet-induced diabetes.45 This report should
therefore prompt a re-evaluation of the role of ER stress in islet
dysfunction and the potential use of pharmacological inhibitors of
the UPR in the treatment of type-2 diabetes.
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